Jishnu Bhattacharjee

Managing Memberat Nexus Ventures Management, LLC· CA
Current roles
3
Investments attributed
5
Board seats
4
Form D directors and board-seat deals
As of · this person's identity; each section below carries its own date

1 additional role or seat, 2 additional attributed investments

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 2 deals
    12 months

    2 investments attributed in the last 12 months; latest Iambic Therapeutics round on 8 Apr 2026.

    A partner with a recent deal is actively writing cheques now.

    Factfunding announcements and Form D naming the personFor Founders, co-investorsInvestments →
  2. 4 boards
    seats on record

    Sits on 4 boards on record, the latest Iambic Therapeutics on 8 Apr 2026.

    Board seats show where this partner holds governance, not only a cheque.

    InferenceForm D directors and board-seat attributionsFor Founders, co-investorsBoard seats →
Drawing the relationship network…

Roles

3 current, 0 past
  • Nexus Ventures Advisors Private Limited Owner
    Jan 1, 2022 to present · “Schedule A: BHATTACHARJEE, JISHNU, OWNER, since 01/2022, ownership E, control person Y”
  • Nexus Ventures Management, LLC Managing Member
    Jan 1, 2021 to present · “Schedule A: BHATTACHARJEE, JISHNU, MANAGING MEMBER, since 01/2021, ownership E, control person Y”
  • Nexus Venture Partners Managing Director
    ? to present · “"The Obot team has a proven track record of building critical open-source infrastructure platforms for developers and enterprises," said Jishnu Bhattacharjee, M”

Investments attributed to this person

5
CompanyRoundInvestorAttributionDateSource
Iambic Therapeutics, Inc.board onlyNexus Ventures Management, LLCstrongly supported · boardApr 8, 2026Inference sec.gov
Onehop Incboard onlyNexus Ventures Management, LLCstrongly supported · boardDec 9, 2025Inference sec.gov
Obot AISeed · $35.0M · SeedNexus Venture PartnersconfirmedSep 23, 2025Fact prnewswire.com

Board seats and vehicles

4 boards, 3 vehicles

Timeline

5 dated entries: events, attributed deals, board seats and role changes
  1. Apr 8, 2026
    Board seat at Iambic Therapeutics, Inc. (Nexus Ventures Management, LLC)
    Board seat Inference Iambic Therapeutics, Inc. Form D
  2. Dec 9, 2025
    Board seat at Onehop Inc (Nexus Ventures Management, LLC)
    Board seat Inference Onehop Inc Form D
  3. Sep 23, 2025
    Seed in Obot AI (Nexus Venture Partners)
    Attributed investment Fact Obot AI Press release
  4. Jan 1, 2022
    Joined Nexus Ventures Advisors Private Limited as Owner
  5. Jan 1, 2021
    Joined Nexus Ventures Management, LLC as Managing Member